Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Danielle Kellar

1PUBLICATIONS

22CO-AUTHORS

Molecular targets

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (1)

Sort by Publication Date:

|Mar 21, 2025

23ME-01473, an Fc Effector-Enhanced Anti-ULBP6/2/5 Antibody, Restores NK Cell-Mediated Antitumor Immunity through NKG2D and FcγRIIIa Activation.

Joel S Benjamin, Abigail Jarret, Shashank Bharill

Pageof 1

Frequent Collaborators

1 joint publications

Joel S Benjamin

1 joint publications

Abigail Jarret

1 joint publications

Shashank Bharill

1 joint publications

Pierre Fontanillas

1 joint publications

Shruti Yadav

1 joint publications

Debasish Sen

1 joint publications

Dina Ayupova

1 joint publications

Susanne Tilk

1 joint publications

Clifford Hom

1 joint publications

Zahra Bahrami Dizicheh

Frequent Collaborators

1 joint publications

Joel S Benjamin

1 joint publications

Abigail Jarret

1 joint publications

Shashank Bharill

1 joint publications

Pierre Fontanillas

Top Related Videos

Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies

Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies

Published on : May 22, 2020

See more related videos

Top Related Videos

Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies

Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies

Published on : May 22, 2020

See more related videos